APGE Q3 2023 Earnings — Apogee Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

APGEApogee Therapeutics, Inc.

$4B

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$24M

Net Income

-$21M

EPS (Diluted)

$-0.41

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$426M

Total Liabilities

$17M

Stockholders' Equity

$409M

Cash & Equivalents

$188M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$24M	-$11M	-131.3%
Net Income	-$21M	-$20M	-6.0%